Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 25
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Whither Magnetic Hyperthermia? A Tentative Roadmap

  • Rubia-Rodríguez, Irene
  • Santana Otero, Antonio
  • Spassov, Simo
  • Tombácz, Etelka
  • Johansson, Christer
  • De La Presa, Patricia
  • Teran, Francisco J.
  • del Puerto Morales, María
  • Veintemillas-Verdaguer, Sabino
  • Thanh, Nguyen T. K.
  • Besenhard, Maximilian O.
  • Wilhelm, Claire
  • Gazeau, Florence
  • Harmer, Quentin
  • Mayes, Eric
  • Manshian, Bella B.
  • Soenen, Stefaan J.
  • Gu, Yuanyu
  • Millán, Ángel
  • Efthimiadou, Eleni K.
  • Gaudet, Jeff
  • Goodwill, Patrick
  • Mansfield, James
  • Steinhoff, Uwe
  • Wells, James
  • Wiekhorst, Frank
  • Ortega Ponce, Daniel
The scientific community has made great efforts in advancing magnetic hyperthermia for the last two decades after going through a sizeable research lapse from its establishment. All the progress made in various topics ranging from nanoparticle synthesis to biocompatibilization and in vivo testing have been seeking to push the forefront towards some new clinical trials. As many, they did not go at the expected pace. Today, fruitful international cooperation and the wisdom gain after a careful analysis of the lessons learned from seminal clinical trials allow us to have a future with better guarantees for a more definitive takeoff of this genuine nanotherapy against cancer. Deliberately giving prominence to a number of critical aspects, this opinion review offers a blend of state-of-the-art hints and glimpses into the future of the therapy, considering the expected evolution of science and technology behind magnetic hyperthermia., This work was supported by the NoCanTher project, which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 685795. The authors acknowledge support from the COST Association through the COST actions "RADIOMAG" (TD1402) and "MyWAVE" (CA17115). D.O., A.S.-O. and I.R.-R. acknowledge financial support from the Community of Madrid under Contracts No. PEJD-2017-PRE/IND-3663 and PEJ-2018-AI/IND-11069, from the Spanish Ministry of Science through the Ramon y Cajal grant RYC2018-025253-I and Research Networks RED2018-102626-T, as well as the Ministry of Economy and Competitiveness through the grants MAT2017-85617-R, MAT2017-88148R and the "Severo Ochoa" Program for Centers of Excellence in R&D (SEV-2016-0686). M.B. and N.T.K.T. would like to thank EPSRC for funding (grant EP/K038656/1 and EP/M015157/1) and AOARD (FA2386-171-4042) award. This work was additionally supported by the EMPIR program co-financed by the Participating States and from the European Union's Horizon 2020 research and innovation program, grant no. 16NRM04 "MagNaStand". The work was further supported by the DFG grant CRC "Matrix in Vision" (SFB 1340/1 2018, no 372486779, project A02).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Heating of metallic biliary stents during magnetic hyperthermia of patients with pancreatic ductal adenocarcinoma: an in silico study

  • Bottauscio, Oriano
  • Rubia-Rodríguez, Irene
  • Arduino, Alessandro
  • Zilberti, Luca
  • Chiampi, Mario
  • Ortega Ponce, Daniel
Objective To investigate the eddy current heating that occurs in metallic biliary stents during magnetic hyperthermia treatments and to assess whether these implants should continue to be an exclusion criterion for potential patients. Methods Computer simulations were run on stent heating during the hyperthermia treatment of local pancreatic tumors (5-15 mT fields at 300 kHz for 30 min), considering factors such as wire diameter, type of stent alloy, and field orientation. Maxwell's equations were solved numerically in a bile duct model, including the secondary field produced by the stents. The heat exchange problem was solved through a modified version of the Pennes' bioheat equation assuming a temperature dependency of blood perfusion and metabolic heat. Results The choice of alloy has a large impact on the stent heating, preferring those having a lower electrical conductivity. Only for low field intensities (5 mT) and for some of the bile duct tissue layers the produced heating can be considered safe. The orientation of the applied field with respect to the stent wires can give rise to the onset of regions with different heating levels depending on the shape that the stent has finally adopted according to the body's posture. Bile helps to partially dissipate the heat that is generated in the lumen of the bile duct, but not at a sufficient rate. Conclusion The safety of patients with pancreatic cancer wearing metallic biliary stents during magnetic hyperthermia treatments cannot be fully assured under the most common treatment parameters.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

In silico assessment of collateral eddy current heating in biocompatible implants subjected to magnetic hyperthermia treatments

  • Rubia-Rodríguez, Irene
  • Zilberti, Luca
  • Arduino, Alessandro
  • Bottauscio, Oriano
  • Chiampi, Mario
  • Ortega Ponce, Daniel
Purpose: Bearing partially or fully metallic passive implants represents an exclusion criterion for patients undergoing a magnetic hyperthermia procedure, but there are no specific studies backing this restrictive decision. This work assesses how the secondary magnetic field generated at the surface of two common types of prostheses affects the safety and efficiency of magnetic hyperthermia treatments of localized tumors. The paper also proposes the combination of a multi-criteria decision analysis and a graphical representation of calculated data as an initial screening during the preclinical risk assessment for each patient. Materials and methods: Heating of a hip joint and a dental implant during the treatment of prostate, colorectal and head and neck tumors have been assessed considering different external field conditions and exposure times. The Maxwell equations including the secondary field produced by metallic prostheses have been solved numerically in a discretized computable human model. The heat exchange problem has been solved through a modified version of the Pennes’ bioheat equation assuming a temperature dependency of blood perfusion and metabolic heat, i.e. thermorregulation. The degree of risk has been assessed using a risk index with parameters coming from custom graphs plotting the specific absorption rate (SAR) vs temperature increase, and coefficients derived from a multi-criteria decision analysis performed following the MACBETH approach. Results: The comparison of two common biomaterials for passive implants - Ti6Al4V and CoCrMo - shows that both specific absorption rate (SAR) and local temperature increase are found to be higher for the hip prosthesis made by Ti6Al4V despite its lower electrical and thermal conductivity. By tracking the time evolution of temperature upon field application, it has been established that there is a 30 s delay between the time point for which the thermal equilibrium is reached at prostheses and tissues. Likewise, damage may appear in those tissues adjacent to the prostheses at initial stages of treatment, since recommended thermal thresholds are soon surpassed for higher field intensities. However, it has also been found that under some operational conditions the typical safety rule of staying below or attain a maximum temperature increase or SAR value is met. Conclusion: The current exclusion criterion for implant-bearing patients in magnetic hyperthermia should be revised, since it may be too restrictive for a range of the typical field conditions used. Systematic in silico treatment planning using the proposed methodology after a well-focused diagnostic, This work has been supported by the NoCanTher project, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No [685795]. The authors acknowledge support from the COST Association through the COST actions `RADIOMAG' [TD1402] and `MyWAVE' [CA17115]. D.O. and I.R.R. acknowledge financial support from the Community of Madrid under Contract No. [PEJD-2017-PRE/IND-3663], from the Error! Hyperlink reference not valid. through the Ramon y Cajal grant [RYC2018-025253-I] and Research Networks [RED2018-102626-Hiroshima], as well as the Ministry of Economy and Competitiveness through the grants [MAT2017-85617R] and the `Severo Ochoa' Program for Centers of Excellence in R&D [SEV-2016-0686]. We gratefully acknowledge the support of NVIDIA Corporation through the GPU Grant Program with the donation of the Quadro P6000 GPU used for this research. D. O. acknowledges support from the Programme for the Promotion and Encouragement of Research and Transfer activities at the University of Cadiz.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Datos de investigación Set de datos (Dataset)

Dataset from "In silico assessment of collateral eddy current heating in biocompatible implants subjected to magnetic hyperthermia treatments"

  • Rubia-Rodríguez, Irene
  • Zilberti, Luca
  • Arduino, Alessandro
  • Bottauscio, Oriano
  • Chiampi, Mario
  • Ortega Ponce, Daniel
This dataset from the publication entitled "Dataset from "In silico assessment of collateral eddy current heating in biocompatible implants subjected to magnetic hyperthermia treatments" contains simulated data of magnetic hyperthermia treatments for three different indications: colorectal cancer, prostate cancer and head & neck cancer. Since the aim of the study is to evaluate the risk of thermal damage caused by the collateral heating of two common types of passive prostheses (hip and dental implants), eddy currents induced in these implants upon interacting with the externally applied ac field during treatment have been computed for all the evaluated regions. Two different alloys for the implants have been considered for each case as well: Ti6Al4V and CoCrMo. At the same time, besides temperature, the specific abosorption rate (SAR) have been also computed to work out the energy deposition in tissues. Calculations have been carried out using a het exchange model with and without thermoregulation. log-log SAR vs T plots have been obtained and proposed as a quick means to pre-check treatment feasibility in each patient. These graphs are thought to be included in treatment planning prior to the clinical procedure. Other parameters taken into account have been the treatment time (5 and 30 minutes), and the maximum tolerable temperature threshold (1 or 5 ºC, as indicated by the ICNIRP commission), all for three main types of tissues, namely fat, bone and muscle. Each tissue have been simulated using three different field intensities (5, 10 and 15 mT). The field frequency has been 300 kHz in all cases. The files "Dataset_description.doc" and "file_scheme.txt" contain the structure and description of the files that make up the dataset. UPDATES FROM PREVIOUS VERSIONS: simulations of the dental implant without thermoregulation have been added.
Repositorio Institucional del Instituto Madrileño de Estudios Avanzados en Nanociencia
Publicación Artículo científico (JournalArticle)

The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt

  • Sanhaji M.
  • Göring J.
  • Couleaud P.
  • Aires A.
  • Cortajarena A.L.
  • Courty J.
  • Prina-Mello A.
  • Stapf M.
  • Ludwig R.
  • Volkov Y.
  • Latorre A.
  • Somoza, Álvaro
  • Miranda, Rodolfo
  • Hilger I.
Repositorio Institucional del Instituto Madrileño de Estudios Avanzados en Nanociencia
Publicación Artículo científico (JournalArticle)

Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives

  • Piehler S.
  • Dähring H.
  • Grandke J.
  • Göring J.
  • Couleaud P.
  • Aires A.
  • Cortajarena A.L.
  • Courty J.
  • Latorre A.
  • Somoza, Álvaro
  • Teichgräber U.
  • Hilger I.
Repositorio Institucional del Instituto Madrileño de Estudios Avanzados en Nanociencia
Publicación Artículo científico (JournalArticle)

Tailored functionalized magnetic nanoparticles to target breast cancer cells including cancer stem-like cells

  • Lazaro-Carrillo A.
  • Calero M.
  • Aires A.
  • Cortajarena A.L.
  • Simões B.M.
  • Latorre A.
  • Somoza, Álvaro
  • Clarke R.B.
  • Miranda, Rodolfo
  • Villanueva A.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

  • Nicolas Boluda, Alba
  • Vaquero, Javier
  • Vimeux, Lene
  • Guilbert, Thomas
  • Barrin, Sarah
  • Kantari Mimoun, Chahrazade
  • Ponzo, Matteo
  • Renault, Gilles
  • Deptula, Piotr
  • Pogoda, Katarzyna
  • Bucki, Robert
  • Cascone, Ilaria
  • Courty, José
  • Fouassier, Laura
  • Gazeau, Florence
  • Donnadieu, Emmanuel
Only a fraction of cancer patients benefits from immune checkpoint inhibitors. This may be partly due to the dense extracellular matrix (ECM) that forms a barrier for T cells. Comparing five preclinical mouse tumor models with heterogeneous tumor microenvironments, we aimed to relate the rate of tumor stiffening with the remodeling of ECM architecture and to determine how these features affect intratumoral T cell migration. An ECM-targeted strategy, based on the inhibition of lysyl oxidase, was used. In vivo stiffness measurements were found to be strongly correlated with tumor growth and ECM crosslinking but negatively correlated with T cell migration. Interfering with collagen stabilization reduces ECM content and tumor stiffness leading to improved T cell migration and increased efficacy of anti-PD-1 blockade. This study highlights the rationale of mechanical characterizations in solid tumors to understand resistance to immunotherapy and of combining treatment strategies targeting the ECM with anti-PD-1 therapy.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Smartphone‐based colorimetric method to quantify iron concentration and to determine the nanoparticle size from suspensions of magnetic nanoparticles

  • Fernández-Afonso, Yilian
  • Salas, Gorka
  • Fernández-Barahona, Irene
  • Herranz, Fernando
  • Grüttner, Cordula
  • Fuente, Jesús M. de la
  • Morales, María Del Puerto
  • Gutiérrez, Lucía
Advanced uses of smartphones are changing lifestyles, and may have a great impact in materials science in the near future. In this work, the use of these devices to develop fast, simple, and cheap methods to characterize magnetic nanoparticle suspensions is tested. A series of dilutions of a wide library of magnetic nanoparticles, composed of iron oxide materials in the range between 3 and 43 nm, with two different shapes and four different coatings is prepared. The colloid color is analyzed using the RGB (red, green, blue) color model. Ratios of these parameters are correlated with the suspension iron concentration and with the nanoparticles average size. A linear relationship between the color (in particular the G/R ratio) and both the colloid iron content and the particles size is found. The link between these parameters allows the development of two new methods to determine either the concentration or the particle size of magnetic nanoparticle suspensions just by acquiring images from suspensions of iron oxide magnetic nanoparticles with a smartphone., This work was funded by European Commission (project NoCanTher, H2020, GA 685795), Spanish MINECO (SAF2016‐79593‐P to F.H., MAT2017‐88148R (AEI/FEDER, UE) to M.P.M., MAT2015‐71806‐R to G.S. and PGC2018‐096016‐B‐I00 to L.G.), and Fondo Social de la DGA (grupos DGA). Support from the Nanocare Network (RED2018‐102469‐T financed by the Spanish MCIU) is also acknowledged. Y.F‐A. thanks Santander‐Universidad Zaragoza Fellowship program for her Ph.D. position. L.G. acknowledges financial support from the Ramón y Cajal program (RYC‐2014‐15512)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The influence of cation incorporation and leaching in the properties of Mn-doped nanoparticles for biomedical applications

  • García-Soriano, David
  • Amaro, Rebeca
  • Lafuente-Gómez, Nuria
  • Milán-Rois, Paula
  • Somoza, Álvaro
  • Navío, Cristina
  • Herranz, Fernando
  • Gutiérrez, Lucía
  • Salas, Gorka
[Hypothesis]: Superparamagnetic MnxFe3-xO4 nanoparticles are promising materials for applications in biomedicine and other fields. Small variations in the Mn/Fe ratio have a strong impact on the properties of the nanoparticles. Those variations may be caused by the synthesis itself and by common post-synthesis manipulations like surface modification., [Experiments]: Mn-ferrite nanoparticles have been prepared changing systematically the Mn/Fe ratio of the metal precursors and repeating each reaction three times. Nanoparticles were subjected to surface modification with two different and typical molecules to stabilize them in aqueous media. The discrepancy in the Mn/Fe ratios of the precursors with the ones measured after the synthesis and the surface modification have been studied, as well as its impact on the saturation magnetization, blocking temperature, contrast enhancement for magnetic resonance imaging, magnetic heating, and on the cytotoxicity., [Findings]: Mn is incorporated in the nanoparticles in a relatively lower amount than Fe and, as this report shows for the first time, both Mn and Fe ions leach out from the nanoparticles during the surface modification step. The blocking temperature decreases exponentially as the Mn/Fe ratio increases. The transverse and longitudinal relaxation times and the magnetic heating ability change appreciably even with small variations in the composition., This work was supported by the Spanish Ministry of Economy and Competitiveness (project MAT2015-71806-R, SAF2017-87305-R, PGC2018-096016-B-I00), Comunidad de Madrid (projects P2018/NMT-4321, NANOMAGCOST-CM, and B2017/BMD-3867, RENIM-CM), and European Commission H2020 programme (project NOCANTHER, grant agreement no. 685795). IMDEA Nanociencia acknowledges support from the 'Severo Ochoa' Programme for Centres of Excellence in R&D (grant SEV-2016-0686). DG-S gratefully acknowledges Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo (PEJD-2016/IND-2293 fellowship), PMR acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686), NLG thanks the Spanish Education Ministry for the funding (FPU18/02323) and Ayuntamiento de Madrid for the grant to live at Residencia de Estudiantes del CSIC. L.G. acknowledges financial support from the Ramón y Cajal program (RYC-2014-15512)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Combining Ag and γ-Fe2O3 properties to produce effective antibacterial nanocomposites

  • Luengo, Yurena
  • Sot, Begoña
  • Salas, Gorka
The antibacterial activity of hybrid γ-Fe2O3/Ag nanocomposites against the bacterial pathogens E. coli (Gram-negative) and S. aureus (Gram-positive) has been studied. Silver is a well-known bactericidal agent and γ-Fe2O3 nanoparticles release heat when they are exposed to alternating magnetic fields. The combination of both properties to fight infections has not been previously explored. The nanocomposites were synthesized through reduction of silver nitrate in the presence of pre-synthesized superparamagnetic γ-Fe2O3 nanoparticles. Changing systematically the ratio of γ-Fe2O3 and silver precursor and the temperature of the reaction allowed obtaining superparamagnetic nanocomposites with different Ag contents and particle sizes. The antibacterial activity of the samples was tested, and the minimum inhibitory concentrations and minimum bactericidal concentrations of the nanocomposites were determined to compare the microbicidal activity of the samples. It was found that it is related with the release of silver ions from the nanocomposites. Finally, we studied the combination of the bactericidal effect of silver and magnetic hyperthermia finding a synergetic effect between them when plates containing E. coli or S. aureus bacteria with γ-Fe2O3/Ag nanocomposites were subjected to an alternating magnetic field. This effect is related with an increase in the release of silver ions due to that heat dissipation., This work has been partially funded by the Spanish Ministry of Economy and Competitiveness (projects SAF2017-87305-R and MAT2015-71806-R), the Madrid Regional Government (NANOMAGCOST-CM P2018/NMT-4321) and the European Commission’s H2020 program (NoCanTher project, grant agreement No. 685795).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endocytosis-driven gold nanoparticle fractal rearrangement in cells and its influence on photothermal conversion

  • Mulens-Arias, Vladimir
  • Balfourier, Alice
  • Nicolás-Boluda, Alba
  • Carn, Florent
  • Gazeau, Florence
Cellular endocytosis and intracellular trafficking of nanoparticles induce dynamic rearrangements that profoundly modify the physical properties of nanoparticle and govern their biological outcomes when activated by external fields. The precise structure, organization, distribution, and density of gold nanoparticles (AuNPs) confined within intracellular compartments such as lysosomes have not been studied comprehensively, hampering the derivation of predictive models of their therapeutic activity within the cells of interest. By using transmission electron microscopy and small-angle X-ray scattering, we have determined that canonical spherical citrate-coated AuNPs in the 3–30 nm size range form fractal clusters in endolysosomes of macrophages, endothelial cells, and colon cancer cells. Statistical analysis revealed that the cluster size and endolysosome size are correlated but do not depend on the size of AuNPs unless larger preformed aggregates of AuNPs are internalized. Smaller AuNPs are confined in greater numbers in loose aggregates covering a higher fraction of the endolysosomes compared to the largest AuNPs. The fractal dimensions of intracellular clusters increased with the particle size, regardless of the cell type. We thus analyzed how these intracellular structure parameters of AuNPs affect their optical absorption and photothermal properties. We observed that a 2nd plasmon resonance band was shifted to the near-infrared region when the nanoparticle size and fractal dimensions of the intracellular cluster increased. This phenomenon of intracellular plasmon coupling is not directly correlated to the size of the intralysosomal cluster or the number of AuNPs per cluster but rather to the compacity of the cluster and the size of the individual AuNPs. The intracellular plasmon-coupling phenomenon translates to an efficient heating efficiency with the excitation of the three cell types at 808 nm, transforming the NIR-transparent canonical AuNPs with sizes below 30 nm into NIR-absorbing clusters in the tumor microenvironment. Harnessing the spontaneous clustering of spherical AuNPs by cells might be a more valuable strategy for theranostic purposes than deploying complex engineering to derive NIR-absorbent nanostructures out of their environment. Our paper sheds light on AuNP intracellular reorganization and proposes a general method to link their intracellular fates to their in situ physical properties exploited in medical applications., This work has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 685795 and 801305. The authors thank the ANR CarGold-16-CE09-026, ANR Coligomere-18-CE06-0006 and ANR CycLys-18-CE09-0015-01. VMA received a Post-doc fellowship from Association pour le Recherche contre le Cancer (ARC, Aides Individuelles, post-doctorant, dossier 20150603405). ANB received a PhD fellowship by the Institute thematique multi-organismes (ITMO) Cancer and the doctoral school Frontières du Vivant (FdV) – Programme Bettencourt. AB received a PhD fellowship by the doctoral school Physique en Ile de France (EDPIF). This work was supported by the ITMO-Inserm Plan Cancer 2014-2019.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives

  • Piehler, Susann
  • Dähring, Heidi
  • Grandke, Julia
  • Göring, Julia
  • Couleaud, Pierre
  • Aires, Antonio
  • Cortajarena, Aitziber L.
  • Courty, José
  • Latorre, Alfonso
  • Somoza, Álvaro
  • Teichgräber, Ulf
  • Hilger, Ingrid
© 2020 by the authors., There is still a need for improving the treatment of breast cancer with doxorubicin (DOX). In this paper, we functionalized magnetic nanoparticles (MNPs) with DOX and studied the DOX-induced antitumor effects in breast cancer cells (BT474) in the presence of magnetic hyperthermia (43 °C, 1 h). We show that i) intratumoral application of DOX-functionalized MNPs (at least at a concentration of 9.6 nmol DOX/100 mm3 tumor volume) combined with magnetic hyperthermia favors tumor regression in vivo, and there is evidence for an increased effect compared to magnetic hyperthermia alone or to the intratumoral application of free DOX and ii) the presence of the pseudopeptide NucAnt (N6L) on the MNP surface might well be beneficial in its function as carrier for MNP internalization into breast cancer cells in vitro, which could further augment the possibility of the induction of intracellular heating spots and cell death in the future., The described work was carried out within the project “Multifunctional Nanoparticles for the Selective Detection and Treatment of Cancer” (Multifun), funded by the European Commission (Nr. 262943) and in parts by the European Union’s Horizon 2020 research and innovation program under grant agreement No 685795 and the Spanish Ministry of Economy and Competitiveness (SAF2017-87305-R). IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Smartphone-Based Colorimetric Method to Quantify Iron Concentration and to Determine the Nanoparticle Size from Suspensions of Magnetic Nanoparticles

  • Fernández-Afonso, Yilian
  • Salas, Gorka
  • Fernández-Barahona, Irene
  • Herranz, Fernando
  • Grüttner, Cordula
  • Fuente, Jesús M. de la
  • Morales, María Del Puerto
  • Gutiérrez, Lucía
Advanced uses of smartphones are changing lifestyles, and may have a great impact in materials science in the near future. In this work, the use of these devices to develop fast, simple, and cheap methods to characterize magnetic nanoparticle suspensions is tested. A series of dilutions of a wide library of magnetic nanoparticles, composed of iron oxide materials in the range between 3 and 43 nm, with two different shapes and four different coatings is prepared. The colloid color is analyzed using the RGB (red, green, blue) color model. Ratios of these parameters are correlated with the suspension iron concentration and with the nanoparticles average size. A linear relationship between the color (in particular the G/R ratio) and both the colloid iron content and the particles size is found. The link between these parameters allows the development of two new methods to determine either the con- centration or the particle size of magnetic nanoparticle suspensions just by acquiring images from suspensions of iron oxide magnetic nanoparticles with a smartphone., This work was funded by European Commission (project NoCanTher, H2020, GA 685795), Spanish MINECO (SAF2016-79593-P to F.H., MAT2017-88148R (AEI/FEDER, UE) to M.P.M., MAT2015-71806-R to G.S. and PGC2018-096016-B-I00 to L.G.), and Fondo Social de la DGA (grupos DGA). Support from the Nanocare Network (RED2018-102469-T financed by the Spanish MCIU) is also acknowledged. Y.F-A. thanks Santander- Universidad Zaragoza Fellowship program for her Ph.D. position. L.G. acknowledges financial support from the Ramón y Cajal program (RYC- 2014-15512). G.S. acknowledges technical support from Dr. Leonor de la Cueva and Rebeca Amaro. Authors would like to acknowledge the use the Advanced Microscopy Laboratory (INA-Universidad de Zaragoza).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment

  • Cordani, Marco
  • Somoza, Álvaro
© The Author(s) 2018., Despite the extensive genetic and phenotypic variations present in the different tumors, they frequently share common metabolic alterations, such as autophagy. Autophagy is a self-degradative process in response to stresses by which damaged macromolecules and organelles are targeted by autophagic vesicles to lysosomes and then eliminated. It is known that autophagy dysfunctions can promote tumorigenesis and cancer development, but, interestingly, its overstimulation by cytotoxic drugs may also induce cell death and chemosensitivity. For this reason, the possibility to modulate autophagy may represent a valid therapeutic approach to treat different types of cancers and a variety of clinical trials, using autophagy modulators, are currently employed. On the other hand, recent progress in nanotechnology offers plenty of tools to fight cancer with innovative and efficient therapeutic agents by overcoming obstacles usually encountered with traditional drugs. Interestingly, nanomaterials can modulate autophagy and have been exploited as therapeutic agents against cancer. In this article, we summarize the most recent advances in the application of metallic nanostructures as potent modulators of autophagy process through multiple mechanisms, stressing their therapeutic implications in cancer diseases. For this reason, we believe that autophagy modulation with nanoparticle-based strategies would acquire clinical relevance in the near future, as a complementary therapy for the treatment of cancers and other diseases., This work was partially supported by the Spanish Ministry of Economy and Competitiveness (SAF2017-87305-R), Comunidad de Madrid (IND2017/IND-7809; S2017/BMD-3867), co-financed by European Structural and Investment Fund, Asociación Española Contra el Cáncer (Singulares 2014), the European Union’s Horizon 2020 research and innovation programme under Grant agreement no 685795 and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications

  • Cotin, Geoffrey
  • Blanco-Andujar, Cristina
  • Perton, Francis
  • Asín, Laura
  • Fuente, Jesús M. de la
  • Reichardt, Wilfried
  • Schaffner, Denise
  • Ngyen, Dinh-Vu
  • Mertz, Damien
  • Kiefer, Céline
  • Meyer, Florent
  • Spassov, Simo
  • Ersen, Ovidiu
  • Chatzidakis, Michael
  • Botton, Gianluigi A.
  • Hénoumont, Céline
  • Laurent, Sophie
  • Grenèche, Jean Marc
  • Teran, Francisco J.
  • Ortega, Daniel
  • Felder-Flesch, Delphine
  • Begin-Colin, Sylvie
Iron oxide nanoparticles (IONPs) are well-known contrast agents for MRI for a wide range of sizes and shapes. Their use as theranostic agents requires a better understanding of their magnetic hyperthermia properties and also the design of a biocompatible coating ensuring their stealth and a good biodistribution to allow targeting of specific diseases. Here, biocompatible IONPs of two different shapes (spherical and octopod) were designed and tested in vitro and in vivo to evaluate their abilities as high-end theranostic agents. IONPs featured a dendron coating that was shown to provide anti-fouling properties and a small hydrodynamic size favoring an in vivo circulation of the dendronized IONPs. While dendronized nanospheres of about 22 nm size revealed good combined theranostic properties (r2 = 303 mM s−1, SAR = 395 W gFe−1), octopods with a mean size of 18 nm displayed unprecedented characteristics to simultaneously act as MRI contrast agents and magnetic hyperthermia agents (r2 = 405 mM s−1, SAR = 950 W gFe−1). The extensive structural and magnetic characterization of the two dendronized IONPs reveals clear shape, surface and defect effects explaining their high performance. The octopods seem to induce unusual surface effects evidenced by different characterization techniques while the nanospheres show high internal defects favoring Néel relaxation for magnetic hyperthermia. The study of octopods with different sizes showed that Néel relaxation dominates at sizes below 20 nm while the Brownian one occurs at higher sizes. In vitro experiments demonstrated that the magnetic heating capability of octopods occurs especially at low frequencies. The coupling of a small amount of glucose on dendronized octopods succeeded in internalizing them and showing an effect of MH on tumor growth. All measurements evidenced a particular signature of octopods, which is attributed to higher anisotropy, surface effects and/or magnetic field inhomogeneity induced by tips. This approach aiming at an analysis of the structure–property relationships is important to design efficient theranostic nanoparticles., The Region Alsace, France, and the Labex Chimie des Systemes Complexes, University of Strasbourg, France are gratefully acknowledged for the doctoral fellowship to Geoffrey Cotin. This research project was also co-funded by Labex CSC, Alsace contre le cancer, INCA (project PRTK14, THERAMAG 2014-225) and the INTERREG project NANOTRANSMED. The “NANOTRANSMED” project is co-funded by the European Regional Development Fund (ERDF) and by the Swiss Confederation and the Swiss cantons of Aargau, Basel-Landschaft and Basel-Stadt, in the framework of the INTERREG V Upper Rhine program (“Transcending borders with every project”). The authors thank Morgane Rabineau for epifluorescence imaging and Nadia Messaddeq for TEM imaging of cells. The authors thank the Center for Microscopy and Molecular Imaging (CMMI, supported by the European Regional Development Fund and the Walloon Region). This work was supported by the Fond National de la Recherche Scientifique (FNRS), UIAP VII, ARC Programs of the French Community of Belgium and the Walloon region (Gadolymph and Holocancer programs). All the authors acknowledge the COST action TD1402 “RADIOMAG”. D. Ortega and F. J. Teran acknowledge support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686), the Spanish Ministry of Economy and Competitiveness for the NANOLICO project (MAT2017-85617-R), the Spanish Ministry of Science through the NaNoCAR grant PID2020-117544RB-I00, the Ramón y Cajal grant RYC2018-025253-I and Research Networks grant RED2018-102626-T, the HEATOOLS project (BIO2017-84246-C2-1-R), the Comunidad de Madrid for grant NANOMAGCOST (P2018/NMT-4321), DGA for public funding from Fondo Social (grupos DGA), and the European Commission for the funding received through the H2020 “NoCanTher” project (GA No. 685795)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Whither magnetic hyperthermia? A tentative roadmap

  • Rubia-Rodríguez, Irene
  • Santana-Otero, Antonio
  • Spassov, Simo
  • Tombácz, Etelka
  • Johansson, Christer
  • Presa, Patricia de la
  • Teran, Francisco J.
  • Morales, María Del Puerto
  • Veintemillas-Verdaguer, S.
  • Thanh, Nguyen Thi Kim
  • Besenhard, Maximilian O.
  • Wilhelm, Claire
  • Gazeau, Florence
  • Harmer, Quentin
  • Mayes, Eric
  • Manshian, Bella B.
  • Soenen, Stefaan J.
  • Gu, Yuanyu
  • Millán, Ángel
  • Efthimiadou, Eleni K.
  • Gaudet, Jeff
  • Goodwill, Patrick
  • Mansfield, James
  • Steinhoff, Uwe
  • Wells, James
  • Wiekhorst, Frank
  • Ortega, Daniel
This article belongs to the Special Issue Magnetic Nanoparticles as High-Frequency Nano-Heater., The scientific community has made great efforts in advancing magnetic hyperthermia for the last two decades after going through a sizeable research lapse from its establishment. All the progress made in various topics ranging from nanoparticle synthesis to biocompatibilization and in vivo testing have been seeking to push the forefront towards some new clinical trials. As many, they did not go at the expected pace. Today, fruitful international cooperation and the wisdom gain after a careful analysis of the lessons learned from seminal clinical trials allow us to have a future with better guarantees for a more definitive takeoff of this genuine nanotherapy against cancer. Deliberately giving prominence to a number of critical aspects, this opinion review offers a blend of state-of-the-art hints and glimpses into the future of the therapy, considering the expected evolution of science and technology behind magnetic hyperthermia., This work was supported by the NoCanTher project, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 685795. The authors acknowledge support from the COST Association through the COST actions “RADIOMAG” (TD1402) and “MyWAVE” (CA17115). D.O., A.S.-O. and I.R.-R. acknowledge financial support from the Community of Madrid under Contracts No. PEJD-2017-PRE/IND-3663 and PEJ-2018-AI/IND-11069, from the Spanish Ministry of Science through the Ramón y Cajal grant RYC2018-025253-I and Research Networks RED2018-102626-T, as well as the Ministry of Economy and Competitiveness through the grants MAT2017-85617-R, MAT2017-88148R and the “Severo Ochoa” Program for Centers of Excellence in R&D (SEV-2016-0686). M.B. and N.T.K.T. would like to thank EPSRC for funding (grant EP/K038656/1 and EP/M015157/1) and AOARD (FA2386-17-1-4042) award. This work was additionally supported by the EMPIR program co-financed by the Participating States and from the European Union’s Horizon 2020 research and innovation program, grant no. 16NRM04 “MagNaStand”. The work was further supported by the DFG grant CRC “Matrix in Vision” (SFB 1340/1 2018, no 372486779, project A02)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron oxide-manganese oxide nanoparticles with tunable morphology and switchable MRI contrast mode triggered by intracellular conditions

  • García-Soriano, David
  • Milán-Rois, Paula
  • Lafuente-Gómez, Nuria
  • Navío, Cristina
  • Gutiérrez, Lucía
  • Cussó, Lorena
  • Desco, Manuel
  • Calle, Daniel
  • Somoza, Álvaro
  • Salas, Gorka
Stimuli-responsive nanomaterials are very attractive for biomedical applications. They can be activated through external stimuli or by the physico-chemical conditions present in cells or tissues. Here, we describe the preparation of hybrid iron oxide-manganese oxide core-satellite shell nanostructures that change their contrast mode in magnetic resonance imaging (MRI) from T2 to T1, after being internalized by cells. This occurs by the dissolution of the MnO2 of the shell, preserving intact the iron oxide at the core. First, we study the seeded-growth synthesis of iron oxide-manganese oxide nanoparticles studying the effect of varying the core size of the magnetic seeds and the concentration of the surfactant. This allows tuning the size and shape of the final hybrid nanostructure. Then, we show that the shell can be removed by a redox reaction with glutathione, which is naturally present inside the cells at much higher concentrations than outside the cells. Finally, the dissolution of the MnO2 shell and the change in the contrast mode is confirmed in cell cultures. After this process, the iron oxide nanoparticles at the core remain intact and are still active as heating mediators when an alternating magnetic field is applied., This work was supported by the Ministerio de Ciencia e Innovación (PID2019-106301RB-I00 to GS and PGC2018-096016-B-I00 to L.G.), Instituto de Salud Carlos III (PT20/00044; co‐funded by European Union, European Regional Development Fund, ERDF, “A way of making Europe”), Ministerio de Economía y Competitividad (SAF2017-87305-R), Comunidad de Madrid (fellowships PEJD-2016/IND-2293 and IND2017/IND-7809; projects B2017/BMD-3867; P2018/NMT-4321), European Commission H2020 programme (project NOCANTHER, grant agreement no. 685795), and Asociación Española Contra el Cáncer. IMDEA Nanociencia acknowledges support from the 'Severo Ochoa' Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation. L.G. acknowledges financial support from the Ramón y Cajal program (RYC-2014-15512). N. L-G also thanks the Spanish Education Ministry for the funding (FPU18/02323). P. M-R- acknowledges the support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale

  • Fernández, Paula
  • Pérez de la Lastra, C.
  • Tosat-Bitrian, Carlota
  • Bueso de Barrio, Jesús Alejandro
  • Thompson, Sebastian
  • Sot, Begoña
  • Salas, Gorka
  • Somoza, Álvaro
  • Espinosa, Ana
  • Castellanos, Milagros
  • Palomo, Valle
49 p.-7 fig.-9 tab., The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017–2022), and give a perspective on the future trends and direction that nanomedicine research is taking., This work has been partially supported by MCIN/AEI /10.13039/501100011033 and European Union NextGenerationEU/PRTR (PID2021-128340OA-I00, PID2020-119352RB-I00, PID2021-127033OB-C21 and RTI2018-101050-J-I00), Comunidad de Madrid (S2022/BMD-7403 RENIM-CM and Talento program 2018-T1/IND-1005), European Union’s Horizon 2020 research and innovation programme (grant agreement No 685795), la Caixa Foundation LCF/PR/HA21/52350003, Asociación Española Contra el Cáncer IDEAS21989THOM, MCIN/AEI/10.13039/501100011033 and “ESF investing in your future” (RYC2019-027489-I, RYC2020-029282-I). CTB thanks Ministerio de Educación (FPU18/06310) for the predoctoral fellowship. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D (MINECO, CEX2020-001039-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer

  • Lafuente-Gómez, Nuria
  • Martínez-Mingo, Mario
  • Díaz-Riascos, Zamira Vanessa
  • García-Prats, Belén
  • de la Iglesia, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Campos, Luis A
  • Mancilla-Zamora, Sandra
  • Salas, Gorka
  • Abasolo, Ibane
  • Somoza, Álvaro
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jconrel.2025.113791., Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments. Herein, we propose utilizing magnetic nanoparticles (MNP) for the concurrent delivery of gemcitabine and miRNA34a mimic to target pancreatic cancer cells. The MNP were functionalized with disulfide bonds to selectively release their cargo inside tumor cells. The incorporation of the miRNA34a mimic increased the sensitivity of cells to gemcitabine, especially in BxPC-3 cells. Additionally, the miRNA34a sequence was modified with locked nucleic acids (LNA) to increase stability. The resulting LNA34a showed a stronger cytotoxic effect when combined with gemcitabine, even in PANC-1 cells, which are resistant to the drug. Notably, the modified MNP exhibited less toxicity than their free counterparts when incubated with HaCaT cells, a model of healthy keratinocytes. Additionally, the combined delivery of miRNA34a mimics and gemcitabine using MNP elicited a synergistic cytotoxic effect against pancreatic cancer cells through magnetic hyperthermia. The intratumoral administration of the modified MNP in subcutaneous xenografts of BxPC-3 cells resulted in a sustained increase in temperature when an alternating magnetic field was applied. Notably, the treatment with the MNP functionalized with GEM and LNA34a led to significant changes in the expression of NOTCH1 and NOTCH2 in the tumor, which are direct targets of miRNA34a, as well as HSP70, which is related to the cellular response to stressors like heat., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2023-146982OB-I00, PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cáncer [PRYCO223002PEIN], and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher) and No 814607 (Safe-n-Medtech). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez and Mario Martínez-Mingo thankSpanish Science Ministry [FPU18/02323, FJC2021-048151-I, respectively] for the funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer

  • Lafuente-Gómez, Nuria
  • Martínez-Mingo, Mario
  • Díaz-Riascos, Zamira Vanessa
  • García-Prats, Belén
  • de la Iglesia, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Campos, Luis A
  • Mancilla-Zamora, Sandra
  • Salas, Gorka
  • Abasolo, Ibane
  • Somoza, Álvaro
Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments. Herein, we propose utilizing magnetic nanoparticles (MNP) for the concurrent delivery of gemcitabine and miRNA34a mimic to target pancreatic cancer cells. The MNP were functionalized with disulfide bonds to selectively release their cargo inside tumor cells. The incorporation of the miRNA34a mimic increased the sensitivity of cells to gemcitabine, especially in BxPC-3 cells. Additionally, the miRNA34a sequence was modified with locked nucleic acids (LNA) to increase stability. The resulting LNA34a showed a stronger cytotoxic effect when combined with gemcitabine, even in PANC-1 cells, which are resistant to the drug. Notably, the modified MNP exhibited less toxicity than their free counterparts when incubated with HaCaT cells, a model of healthy keratinocytes. Additionally, the combined delivery of miRNA34a mimics and gemcitabine using MNP elicited a synergistic cytotoxic effect against pancreatic cancer cells through magnetic hyperthermia. The intratumoral administration of the modified MNP in subcutaneous xenografts of BxPC-3 cells resulted in a sustained increase in temperature when an alternating magnetic field was applied. Notably, the treatment with the MNP functionalized with GEM and LNA34a led to significant changes in the expression of NOTCH1 and NOTCH2 in the tumor, which are direct targets of miRNA34a, as well as HSP70, which is related to the cellular response to stressors like heat., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2023-146982OB-I00, PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cáncer [PRYCO223002PEIN], and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher) and No 814607 (Safe-n-Medtech). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez and Mario Martínez-Mingo thankSpanish Science Ministry [FPU18/02323, FJC2021-048151-I, respectively] for the funding. Part of the in vivo work was conducted at the ICTS Nanbiosis, more specifically to the Unit 20 of the Functional Validation & Preclinical Research (FVPR) at VHIR (http://www.nanbiosis.es/portfolio/u20-in-vivo-experimental-platform/)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer

  • Lafuente-Gómez, Nuria
  • Martínez-Mingo, Mario
  • Díaz-Riascos, Zamira Vanessa
  • García-Prats, Belén
  • de la Iglesia, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Campos, Luis A.
  • Mancilla-Zamora, Sandra
  • Salas, Gorka
  • Abasolo, Ibane
  • Somoza, Álvaro
Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments. Herein, we propose utilizing magnetic nanoparticles (MNP) for the concurrent delivery of gemcitabine and miRNA34a mimic to target pancreatic cancer cells. The MNP were functionalized with disulfide bonds to selectively release their cargo inside tumor cells. The incorporation of the miRNA34a mimic increased the sensitivity of cells to gemcitabine, especially in BxPC-3 cells. Additionally, the miRNA34a sequence was modified with locked nucleic acids (LNA) to increase stability. The resulting LNA34a showed a stronger cytotoxic effect when combined with gemcitabine, even in PANC-1 cells, which are resistant to the drug. Notably, the modified MNP exhibited less toxicity than their free counterparts when incubated with HaCaT cells, a model of healthy keratinocytes. Additionally, the combined delivery of miRNA34a mimics and gemcitabine using MNP elicited a synergistic cytotoxic effect against pancreatic cancer cells through magnetic hyperthermia. The intratumoral administration of the modified MNP in subcutaneous xenografts of BxPC-3 cells resulted in a sustained increase in temperature when an alternating magnetic field was applied. Notably, the treatment with the MNP functionalized with GEM and LNA34a led to significant changes in the expression of NOTCH1 and NOTCH2 in the tumor, which are direct targets of miRNA34a, as well as HSP70, which is related to the cellular response to stressors like heat., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2023-146982OB-I00, PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cáncer [PRYCO223002PEIN], and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher) and No 814607 (Safe-n-Medtech). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez and Mario Martínez-Mingo thankSpanish Science Ministry [FPU18/02323, FJC2021-048151-I, respectively] for the funding. Part of the in vivo work was conducted at the ICTS Nanbiosis, more specifically to the Unit 20 of the Functional Validation & Preclinical Research (FVPR) at VHIR (http://www.nanbiosis.es/portfolio/u20-in-vivo-experimental-platform/)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Whither magnetic hyperthermia? A tentative roadmap

  • Rubia-Rodríguez, I.
  • Santana-Otero, A.
  • Spassov, S.
  • Tombácz, E.
  • Johansson, C.
  • De La Presa, P.
  • Teran, F.J.
  • Morales, M.P.
  • Veintemillas-Verdaguer, S.
  • Thanh, N.T.K.
  • Besenhard, M.O.
  • Wilhelm, C.
  • Gazeau, F.
  • Harmer, Q.
  • Mayes, E.
  • Manshian, B.B.
  • Soenen, S.J.
  • Gu, Y.
  • Millán, Á.
  • Efthimiadou, E.K.
  • Gaudet, J.
  • Goodwill, P.
  • Mansfield, J.
  • Steinhoff, U.
  • Wells, J.
  • Wiekhorst, F.
  • Ortega, D.
The scientific community has made great efforts in advancing magnetic hyperthermia for the last two decades after going through a sizeable research lapse from its establishment. All the progress made in various topics ranging from nanoparticle synthesis to biocompatibilization and in vivo testing have been seeking to push the forefront towards some new clinical trials. As many, they did not go at the expected pace. Today, fruitful international cooperation and the wisdom gain after a careful analysis of the lessons learned from seminal clinical trials allow us to have a future with better guarantees for a more definitive takeoff of this genuine nanotherapy against cancer. Deliber-ately giving prominence to a number of critical aspects, this opinion review offers a blend of state-of-the-art hints and glimpses into the future of the therapy, considering the expected evolution of science and technology behind magnetic hyperthermia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Smartphone-based colorimetric method to quantify iron concentration and to determine the nanoparticle size from suspensions of magnetic nanoparticles

  • Fernández-Afonso, Y.
  • Salas, G.
  • Fernández-Barahona, I.
  • Herranz, F.
  • Grüttner, C.
  • Martínez de la Fuente, J.
  • del Puerto Morales, M.
  • Gutiérrez, L.
Advanced uses of smartphones are changing lifestyles, and may have a great impact in materials science in the near future. In this work, the use of these devices to develop fast, simple, and cheap methods to characterize magnetic nanoparticle suspensions is tested. A series of dilutions of a wide library of magnetic nanoparticles, composed of iron oxide materials in the range between 3 and 43 nm, with two different shapes and four different coatings is prepared. The colloid color is analyzed using the RGB (red, green, blue) color model. Ratios of these parameters are correlated with the suspension iron concentration and with the nanoparticles average size. A linear relationship between the color (in particular the G/R ratio) and both the colloid iron content and the particles size is found. The link between these parameters allows the development of two new methods to determine either the concentration or the particle size of magnetic nanoparticle suspensions just by acquiring images from suspensions of iron oxide magnetic nanoparticles with a smartphone.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

  • Nicolas Boluda, Alba
  • Vaquero, Javier
  • Vimeux, Lene
  • Guilbert, Thomas
  • Barrin, Sarah
  • Kantari Mimoun, Chahrazade
  • Ponzo, Matteo
  • Renault, Gilles
  • Deptula, Piotr
  • Pogoda, Katarzyna
  • Bucki, Robert
  • Cascone, Ilaria
  • Courty, José
  • Fouassier, Laura
  • Gazeau, Florence
  • Donnadieu, Emmanuel
Only a fraction of cancer patients benefits from immune checkpoint inhibitors. This may be partly due to the dense extracellular matrix (ECM) that forms a barrier for T cells. Comparing five preclinical mouse tumor models with heterogeneous tumor microenvironments, we aimed to relate the rate of tumor stiffening with the remodeling of ECM architecture and to determine how these features affect intratumoral T cell migration. An ECM-targeted strategy, based on the inhibition of lysyl oxidase, was used. In vivo stiffness measurements were found to be strongly correlated with tumor growth and ECM crosslinking but negatively correlated with T cell migration. Interfering with collagen stabilization reduces ECM content and tumor stiffness leading to improved T cell migration and increased efficacy of anti-PD-1 blockade. This study highlights the rationale of mechanical characterizations in solid tumors to understand resistance to immunotherapy and of combining treatment strategies targeting the ECM with anti-PD-1 therapy.